Corvel Insider Sold Shares Worth $1,933,011, According to a Recent SEC Filing-March 2024-www.financetom.com

Corvel Insider Sold Shares Worth $1,933,011, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Corvel Insider Sold Shares Worth $1,933,011, According to a Recent SEC Filing

Apr 11, 2025 12:52 AM

03:39 AM EDT, 04/11/2025 (MT Newswires) -- Jeffrey J Michael, 10% Owner, Director, on April 09, 2025, sold 16,523 shares in Corvel ( CRVL ) for $1,933,011. Following the Form 4 filing with the SEC, Michael has control over a total of 551,787 common shares of the company, with 551,787 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/874866/000103131825000004/xslF345X05/edgardoc.xml

Previous page： TEAMSTERS: WITHOUT WORKER PROTECTIONS, DOJ MUST BLOCK PARAMOUNT-WARNER MERGER Next page： Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

TEAMSTERS: WITHOUT WORKER PROTECTIONS, DOJ MUST BLOCK PARAMOUNT-WARNER MERGER

Mar 12, 2026

Union Warns Consolidation Risks Layoffs, Industry Stability, and Labor Standards WASHINGTON, March 12, 2026 /PRNewswire/ -- The International Brotherhood of Teamsters told the Department of Justice (DOJ) this week that the proposed merger between Paramount Skydance and Warner Bros. Discovery poses a direct threat to film and television workers nationwide, including nearly 15,000 rank-and-file Motion Picture Teamsters. The 1.3-million-member union...

Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder

Mar 12, 2026

Ultragenyx Pharmaceutical Inc. ( RARE ) shares are down on Thursday as the company reported data from its Phase 3 study of DTX301, a gene therapy for ornithine transcarbamylase (OTC) deficiency. • Ultragenyx Pharmaceutical ( RARE ) shares are sliding. Why is RARE stock dropping? OTC deficiency is an inherited disorder that causes ammonia to accumulate in the blood. OTC...

Disney appoints veteran Paul Roeder as communications chief

Mar 12, 2026

March 12 (Reuters) - Walt Disney ( DIS ) has named 25-year company veteran Paul Roeder as senior executive vice president and chief communications officer, effective March 19, the media giant said on Thursday. The appointment marks one of the recent changes to Disney's ( DIS ) top leadership team since the company named Josh D'Amaro as its new top...

Disney appoints veteran Paul Roeder as communications chief

Mar 12, 2026